ArticleDisease markers2023

Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.

Haoxun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.